About Von Willebrand Disease (VWD)

Overview
Von Willebrand Disease (VWD) is a bleeding disorder that occurs due to a deficiency or dysfunction of a protein called von Willebrand factor (VWF). This protein plays an important role in the initial adhesion of platelets at sites of vascular injury and also helps in binding and stabilizing another protein called blood clotting factor VIII (FVIII) in the bloodstream. When there are defects in VWF, it can lead to bleeding by impairing platelet adhesion or reducing the concentration of FVIII. VWD is relatively common, and its prevalence varies among studies. It has been estimated to affect roughly 23 to 110 out of every million people (0.0023 to 0.01 percent). VWD can cause various symptoms, including easy bruising, prolonged bleeding from wounds or surgeries, joint bleeding, mucocutaneous bleeding (bleeding from mucous membranes), heavy menstrual bleeding (HMB) in women, and potentially life-threatening bleeding in certain situations.
Causes and Risk Factors

The causes of VWD are primarily genetic mutations in the von Willebrand factor gene. These mutations result in a deficiency or functional abnormality of vWF, which is a glycoprotein that plays a crucial role in platelet-vessel wall interactions and acts as a carrier protein for factor VIII, an important clotting factor.

There are both non-modifiable and modifiable risk factors associated with VWD.

Non-modifiable risk factors are factors that cannot be changed. These are:

  • Genetic factors: VWD is an inherited disorder, so having a family history of VWD increases the risk of developing the condition. Children with a parent who has VWD have a 50% chance of inheriting the gene mutation.

Modifiable risk factors are factors that can be changed or influenced. Currently, there are no known modifiable risk factors for VWD. This means that individuals cannot change or modify any lifestyle or environmental factors to prevent the development of VWD.

Symptoms

VWD is a bleeding disorder that can have varying symptoms depending on the type and severity of the disease. Here are the most common early symptoms of VWD:

  • Easy bruising: Individuals with VWD may bruise easily, even from minor injuries or bumps.
  • Excessive nosebleeds: Nosebleeds that occur frequently and are difficult to control are a common symptom of VWD.
  • Bleeding from gums: People with VWD may experience bleeding from their gums, especially during brushing or flossing.
  • Abnormally heavy bleeding during menstruation: Women with VWD may have heavier and prolonged menstrual periods.

As VWD progresses or becomes more severe, other symptoms may occur. Here are some common symptoms associated with later stages, progression, or higher severity of VWD:

  • Internal bleeding: Individuals with severe forms of VWD, particularly Type 3, have a higher risk of internal bleeding. This can include bleeding in the joints and gastrointestinal system.
  • Increased risk during physiologic events: Women are more likely to experience symptoms and complications due to the increased risk of bleeding during menstruation, pregnancy, and childbirth.

It's important to note that the signs and symptoms of VWD can overlap with those of another bleeding disorder called hemophilia. Both conditions can cause easy bruising, recurrent nosebleeds, bleeding gums, and excessive bleeding after trauma or surgery. However, there are some differences in symptoms between the two disorders. People with VWD may experience particularly heavy periods and bleeding from the nose and gums, while those with hemophilia may be more likely to have painful or stiff joints and muscles from internal bleeding.

Diagnosis

To diagnose VWD, healthcare professionals commonly perform the following examinations, tests, and procedures:

  • Medical history: The doctor will ask about your symptoms and any previous diagnoses.
  • Physical Examination: A doctor may conduct a physical examination to check for signs of bleeding, such as bruising or recent cuts. They may also look for physical signs of other medical problems, such as pain, swelling, or masses within the body.
  • Family History: Taking a detailed family history is crucial in diagnosing VWD. This helps determine whether a person may have inherited the condition.
  • Blood Tests: Blood tests play a key role in diagnosing VWD. These tests measure the presence and activity of certain substances in the blood that are involved in blood clotting. Specifically, they evaluate the amount, activity, and structure of von Willebrand factor (VWF) proteins in the blood. VWF is a protein that helps with blood clotting.
  • Genetic Testing: In some cases, genetic testing may be performed to identify changes in genes, chromosomes, or proteins associated with VWD. This test can confirm or rule out a suspected genetic disease and help determine the chances of developing or passing on a genetic disease.
  • Imaging Studies: Depending on the symptoms and specific situation, imaging studies like X-rays or MRIs may be recommended to assess any or complications related to VWD.

It's important to follow up with your healthcare provider if any symptoms worsen or change after the initial physical examination or if you have any concerns. They will guide you through the necessary examinations, tests, and procedures based on your specific situation to provide an accurate diagnosis and determine the stage or severity of VWD.

Treatment Options

The goals of treatment for VWD are to manage bleeding symptoms and improve the quality of life for those with the condition. The specific treatment options and strategies used to achieve these goals may vary depending on the type and severity of VWD.

Medications:

  • Synthetic Injectable Clotting Factors: These medications are used to replace the missing or dysfunctional clotting factors in individuals with VWD. They can be prescribed by healthcare professionals to prevent bleeding or stop active bleeding.
  • Desmopressin (DDAVP): This therapy involves stimulating endothelial cells to release endogenous von Willebrand factor (VWF) stores. By increasing the plasma concentration of VWF, DDAVP can help prevent or control bleeding episodes in some individuals with VWD.

Therapies:

  • VWF Concentrates: These are human plasma-derived concentrates that contain VWF. They are used to replace deficient or dysfunctional VWF in individuals with VWD. VWF concentrates can be effective in preventing or controlling bleeding and promoting hemostasis and wound healing.
  • Prophylactic Treatments: In cases where individuals have more severe forms of VWD or a history of frequent or severe bleeding, prophylactic treatments may be used. This can involve regular infusions of clotting factor concentrates to prevent bleeding episodes.
  • Replacement Therapy: Replacement therapy using a VWF concentrate is indicated for significant bleeding events or major surgery in patients with types 2 and 3 VWD, as well as in patients with type 1 VWD who are unresponsive to DDAVP or require a protracted duration of therapy.

Health Behavior Changes:

  • Medication Management: Individuals with VWD may need to avoid medications such as aspirin that thin the blood, which can increase the risk of bleeding.
  • Consultation with a Hematologist: It is recommended that individuals with VWD speak with a hematologist, a doctor who specializes in blood disorders, before undergoing surgeries, dental work, pregnancy/birth, or any other event that may increase the chance of bleeding. This ensures appropriate management and prevention of bleeding complications.

Each treatment option works differently to achieve the goals of managing bleeding symptoms and improving quality of life for individuals with VWD. It's important for individuals with VWD to work closely with healthcare professionals, particularly hematologists, to determine the most appropriate treatment options based on their type and severity of VWD, as well as their specific hemostatic challenges and potential for bleeding complications.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.

Progression or Complications

Here's what you need to know about the natural progression, complications, and impact of treatment for VWD:

Natural Progression of VWD:

  • VWD is usually autosomal dominant, which means it can be passed down from one generation to another.
  • The severity of symptoms and the progression of VWD can vary greatly among individuals, even within the same family.
  • The bleeding symptoms can range from mild to severe and may include frequent nosebleeds, easy bruising, heavy menstrual bleeding, and prolonged bleeding from cuts or after surgery or dental work.
  • Over time, individuals with VWD may continue to experience these bleeding symptoms. However, the frequency and severity of bleeding episodes can be managed with appropriate treatment.

Complications of VWD:

  • Individuals with VWD are at an increased risk for muco-cutaneous bleeding. This includes epistaxis (nosebleeds), easy bruising, prolonged bleeding after trivial cuts, excessive bleeding with dental procedures, excessive bleeding from the oral cavity, gastrointestinal bleeding, excessive post-operative bleeding, and reproductive tract bleeding.
  • Other complications that can occur in individuals with VWD include excessive blood loss during trauma or surgery.
  • It's important to note that while these complications are associated with VWD, not all individuals with VWD will experience all of these complications.

Early diagnosis and appropriate treatment can help reduce the frequency and severity of bleeding episodes, improve quality of life, and minimize complications associated with VWD.

Remember to always consult with a healthcare professional for advice on managing VWD. They will be able to provide personalized recommendations based on an individual's specific condition.